Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection

Abstract

Maternal oral administration of VACV leads to therapeutic concentrations in the maternal and fetal compartments, with a decrease in VLFB. Our results suggest that in cases where TOP is declined, a randomised controlled trial to study this treatment option further is indicated.